RG Melton
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Biotechnology top 5%
- Cancer Research and Treatments
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 12
- Radiopharmaceutical Chemistry and Applications 6
- Oncology 6
- HER2/EGFR in Cancer Research 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- R.F. Sherwood (6 shared papers)K D Bagshawe (5 shared papers)F Searle (5 shared papers)Springer Cj (2 shared papers)Pari Antoniw (2 shared papers)SK Sharma (1 shared paper)Caroline J. Springer (3 shared papers)Robert I. Dowell (5 shared papers)
- Journals
- British Journal of Cancer (7 papers)Journal of Clinical Oncology (2 papers)Biochemical Pharmacology (1 paper)Journal of Medicinal Chemistry (1 paper)Biochemical Society Transactions (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
RG Melton
17 papers receiving 712 citations
Peers
Comparison fields: 5 of 67
- Radiology, Nuclear Medicine and Imaging 354
- Biotechnology 116
- Oncology 181
- Molecular Biology 403
- Organic Chemistry 132
Countries citing papers authored by RG Melton
This map shows the geographic impact of RG Melton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RG Melton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RG Melton more than expected).
Fields of papers citing papers by RG Melton
This network shows the impact of papers produced by RG Melton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RG Melton. The network helps show where RG Melton may publish in the future.
Co-authors
The 25 scholars most cited alongside RG Melton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 204 | |
| 2 | 2005 | 108 | |
| 3 | 1996 | 81 | |
| 4 | 1995 | 64 | |
| 5 | Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185. | 1994 | 56 |
| 6 | 1996 | 48 | |
| 7 | ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts. | 1996 | 44 |
| 8 | 1990 | 37 | |
| 9 | 1995 | 31 | |
| 10 | 1986 | 27 | |
| 11 | 1990 | 18 | |
| 12 | 1996 | 13 | |
| 13 | 1995 | 11 | |
| 14 | 1990 | 2 | |
| 15 | 2004 | 1 | |
| 16 | 1995 | 1 | |
| 17 | 2004 | 1 |
About RG Melton
RG Melton is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Public Health, Environmental and Occupational Health and Biotechnology, having authored 17 papers that have together received 747 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Cancer Research and Treatments (4 papers), Glycosylation and Glycoproteins Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), HER2/EGFR in Cancer Research (3 papers), Peptidase Inhibition and Analysis (2 papers) and Pregnancy and Medication Impact (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (354 citations), Biotechnology (116 citations), Oncology (181 citations), Molecular Biology (403 citations) and Organic Chemistry (132 citations). RG Melton has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include R.F. Sherwood, K D Bagshawe, F Searle, Springer Cj, Pari Antoniw, SK Sharma, Caroline J. Springer, Robert I. Dowell, D C Blakey and G. Henze. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Biochemical Pharmacology, Journal of Medicinal Chemistry and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.